Wegovy MASH Approval, Singapore HSA Actions, Zydus, Glenmark Q1 Results
Global Pharma & Healthcare Weekly Newsletter Wegovy MASH Approval, Singapore HSA Actions, India Q1 Results Coverage: August 11–17, 2025 Introduction The week delivered two major U.S. approvals (including Wegovy for MASH and the first immunotherapy for recurrent respiratory papillomatosis), notable Indian corporate disclosures, vigorous enforcement actions in Singapore, and several UAE public‑health initiatives. Major News … Read more